This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kennedy, D. D. Articles by Kelly, K. M. Search for Related Content PubMed PubMed Citation Articles by Kennedy, D. D. Articles by Kelly, K. M. Social Bookmarking                   What's this?

8-oxo-dG Elevated in Children During Leukemia Treatment

Division of Pediatric Oncology, Department of Pediatrics, College of Physicians & Surgeons, Columbia University, New York

Regina M. Santella, PhD

Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York

Qiao Wang

Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York

Elena J. Ladas, MS, RD

Division of Pediatric Oncology, Department of Pediatrics, College of Physicians & Surgeons, Columbia University, New York

Kara M. Kelly, MD

Division of Pediatric Oncology, Department of Pediatrics, College of Physicians & Surgeons, Columbia University, New York

Changes in oxidative stress in children undergoing chemotherapy for acute lymphoblastic leukemia (ALL) have not been well documented. To determine whether the measurement of the DNA oxidized base 8-oxodeoxyguanosine (8-oxo-dG) may be a useful biomarker in this population, the authors conducted an observational study on 103 children with ALL. Blood samples were collected at diagnosis, during interim maintenance (IM), and during delayed intensification (DI). Blood mononuclear cell 8-oxo-dG, measured with an immunohistochemical method, decreased from diagnosis to IM (P = .01) and increased between IM and DI (P < .01). In a pilot study, bone marrow was also collected from 16 patients at diagnosis and after 28 days of treatment, but 8-oxo-dG remained the same. The relationship between plasma and dietary intake of antioxidants and the level of 8-oxo-dG was also explored. There was a direct relationship between the intake of vitamin E at diagnosis and bone marrow 8-oxo-dG (P = .03) and an inverse relationship between ß-carotene intake and blood 8-oxo-dG at IM (P = .03) and vitamin A in-take and blood 8-oxo-dG at DI (P = .003). Plasma vitamin C (P = .02) and total carotenoids (P = .01) were inversely related to blood 8-oxo-dG at IM. In contrast, higher plasma E/total lipid levels were associated with higher 8-oxo-dG at IM and DI (P < .01). At IM, patients with higher 8-oxo-dG had an increased risk of chemotherapy dose reduction (P = .04). In conclusion, the level of 8-oxo-dG in blood mononuclear cells decreases after the start of chemotherapy and increases during aggressive chemotherapy in children with ALL.

Key Words: 8-oxo-dG • acute lymphoblastic leukemia • antioxidant • chemotherapy toxicity • nutrition • bone marrow

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. W. Moss Should patients undergoing chemotherapy and radiotherapy be prescribed antioxidants? Integr Cancer Ther, March 1, 2006; 5(1): 63 - 82. [Abstract] [PDF]

				K. I. Block Antioxidants and Cancer Therapy: Furthering the Debate Integr Cancer Ther, December 1, 2004; 3(4): 342 - 348. [Abstract] [PDF]